No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir

A. Ciccullo; A. Dusina; A. P. Lassandro; A. Borghetti; G. Baldin; Simona Di Giambenedetto

doi:10.1097/QAD.0000000000002495

No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir

A. Ciccullo^*
, A. Dusina
, A. P. Lassandro
, A. Borghetti
, G. Baldin
, Simona Di Giambenedetto

^*Autore corrispondente per questo lavoro

Mater Olbia Hospital

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

N/A Not Available

Lingua originale	Inglese
pagine (da-a)	956-957
Numero di pagine	2
Rivista	AIDS
Volume	34
Numero di pubblicazione	6
DOI	https://doi.org/10.1097/QAD.0000000000002495
Stato di pubblicazione	Pubblicato - 2020

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

All Science Journal Classification (ASJC) codes

Immunologia e Allergia
Immunologia
Malattie Infettive

Keywords

3-Ring
Adipose Tissue
Anti-HIV Agents
HIV Infections
Heterocyclic Compounds
Humans
Lamivudine
Oxazines
Piperazines
Pyridones
Weight Gain

Accesso al documento

10.1097/QAD.0000000000002495

Altri file e collegamenti

Cita questo

@article{0d5286306ec54f379aa0512bda2dc77a,

title = "No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir",

abstract = "N/A Not Available",

keywords = "3-Ring, Adipose Tissue, Anti-HIV Agents, HIV Infections, Heterocyclic Compounds, Humans, Lamivudine, Oxazines, Piperazines, Pyridones, Weight Gain, 3-Ring, Adipose Tissue, Anti-HIV Agents, HIV Infections, Heterocyclic Compounds, Humans, Lamivudine, Oxazines, Piperazines, Pyridones, Weight Gain",

author = "A. Ciccullo and A. Dusina and Lassandro, \{A. P.\} and A. Borghetti and G. Baldin and \{Di Giambenedetto\}, Simona",

year = "2020",

doi = "10.1097/QAD.0000000000002495",

language = "English",

volume = "34",

pages = "956--957",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir

AU - Ciccullo, A.

AU - Dusina, A.

AU - Lassandro, A. P.

AU - Borghetti, A.

AU - Baldin, G.

AU - Di Giambenedetto, Simona

PY - 2020

Y1 - 2020

N2 - N/A Not Available

AB - N/A Not Available

KW - 3-Ring

KW - Adipose Tissue

KW - Anti-HIV Agents

KW - HIV Infections

KW - Heterocyclic Compounds

KW - Humans

KW - Lamivudine

KW - Oxazines

KW - Piperazines

KW - Pyridones

KW - Weight Gain

KW - 3-Ring

KW - Adipose Tissue

KW - Anti-HIV Agents

KW - HIV Infections

KW - Heterocyclic Compounds

KW - Humans

KW - Lamivudine

KW - Oxazines

KW - Piperazines

KW - Pyridones

KW - Weight Gain

UR - https://publicatt.unicatt.it/handle/10807/193265

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85083541697&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85083541697&origin=inward

U2 - 10.1097/QAD.0000000000002495

DO - 10.1097/QAD.0000000000002495

M3 - Article

SN - 0269-9370

VL - 34

SP - 956

EP - 957

JO - AIDS

JF - AIDS

IS - 6

ER -

No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir

Abstract

OSS delle Nazioni Unite

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo